correspond
tcell
epitop
respons
vaccin
immunogen
pathogen
antigen
critic
vaccin
efficaci
present
studi
analyz
spectrum
immun
respons
mice
three
differ
form
sar
coronaviru
nucleocapsid
n
exogen
recombin
protein
ngst
freund
adjuv
dna
encod
unmodifi
n
endogen
cytoplasm
protein
pn
dna
encod
n
chimera
target
lysosom
mhc
ii
compart
plampn
lysosom
traffick
lampn
chimera
transfect
cell
document
confoc
immunoelectron
microscopi
respons
immun
mice
differ
markedli
strongest
tcell
ifng
ctl
respons
lampn
chimera
follow
pn
immunogen
contrast
ngst
elicit
strong
cell
minim
ifng
respons
much
greater
antibodi
respons
despit
differ
howev
immunodomin
tcell
elispot
respons
three
immunogen
elicit
n
peptid
greatest
respons
gener
cluster
five
overlap
peptid
n
contain
nonamer
bind
domain
high
bind
score
class
except
n
class
ii
allel
result
demonstr
process
present
n
whether
exogen
endogen
deriv
result
common
immunodomin
epitop
support
use
modifi
antigen
deliveri
traffick
form
particular
lamp
chimera
vaccin
candid
nevertheless
profil
tcell
respons
distinctli
differ
pronounc
humor
respons
n
protein
plu
adjuv
contrast
balanc
ifng
respons
strong
memori
ctl
respons
lampn
chimera
sar
coronaviru
nucleocapsid
immunodomin
tcell
epitop
cluster
common
exogen
recombin
endogen
dnaencod
immunogen
vaccin
design
prevent
viral
infect
must
promot
adapt
expans
cell
associ
band
tcell
longterm
memori
epitop
ident
crossreact
natur
pathogen
welsh
et
al
crotti
ahm
process
present
antigen
epitop
vaccin
immunogen
must
therefor
mimic
pathogen
convent
understand
epitop
present
mhc
class
deriv
endogen
cellular
protein
cleav
proteasom
postproteasom
peptidas
villadango
et
al
yewdel
bennink
kloetzel
epitop
load
mhc
class
ii
molecul
gener
involv
exogen
protein
taken
antigenpres
cell
apc
special
endocyt
receptor
process
proteas
endosomallysosom
compart
moreno
et
al
bryant
ploegh
wide
report
variou
antigenprocess
pathway
may
affect
immun
epitop
format
either
posit
neg
may
influenc
repertoir
tcell
epitopespecif
immun
respons
either
quantit
qualit
pamer
cresswel
kessler
et
al
lautwein
et
al
kloetzel
specif
antigen
process
would
suggest
form
deliveri
immunogen
critic
gener
biolog
effect
antigen
epitop
thu
vaccin
efficaci
howev
abund
evid
present
exogen
antigen
mhc
class
endogen
protein
mhc
class
ii
varieti
altern
antigen
traffick
process
mechan
includ
special
process
pathway
reimann
schirmbeck
norburi
et
al
bonifaz
et
al
imai
et
al
cross
prime
present
brode
macari
tewari
et
al
altern
endolysosom
pathway
brook
et
al
lich
et
al
chen
jondal
vesicular
transloc
rei
e
sousa
germain
ackerman
cresswel
phagocyt
autophag
mechan
antigen
deliveri
mhc
class
ii
compart
houd
et
al
guermonprez
et
al
nimmerjahn
et
al
rocha
tanchot
paludan
et
al
nevertheless
littl
known
consequ
altern
antigen
traffick
process
pathway
product
pathogenspecif
antigen
epitop
thu
examin
tcell
epitop
critic
earli
step
develop
new
gener
vaccin
includ
dna
vaccin
chimera
protein
sequenc
epitopebas
antigen
involv
antigen
nonvir
structur
may
access
process
pathway
differ
follow
nativ
pathogen
issu
regard
pathway
use
antigen
deliveri
process
particularli
relev
mhc
class
ii
epitop
present
antigen
epitop
activ
cell
mhc
class
ii
molecul
critic
step
gener
memori
b
cell
tcell
phenotyp
wang
livingston
failur
elicit
immun
memori
one
recogn
problem
convent
genet
vaccin
maecker
et
al
defect
may
reflect
inadequ
level
antigen
express
restrict
access
mhc
ii
process
present
compart
dnaencod
endogen
antigen
lack
dedic
traffick
pathway
martin
et
al
maecker
et
al
oehen
et
al
rush
et
al
respons
problem
character
dna
vaccin
construct
synthes
form
chimera
link
antigen
sequenc
traffickingtarget
signal
lysosomeassoci
membran
chen
et
al
lamp
molecul
known
traffic
lysosom
special
multilaminar
vesicular
compart
immatur
apc
term
miic
mhc
ii
antigen
process
format
antigen
peptid
mhc
ii
complex
occur
kleijmeer
et
al
geuz
murk
et
al
studi
sever
antigen
includ
env
gag
hpv
cytomegaloviru
carcinoembryon
antigen
dengu
preme
yellow
fever
env
catalyt
subunit
telomeras
revers
transcriptas
htert
express
viral
vector
nake
dna
rna
shown
lamptarget
antigen
gener
greater
antigenspecif
lymphoprolif
activ
antibodi
titer
cytotox
tlymphocyt
activ
dna
construct
encod
wildtyp
antigen
rowel
et
al
wu
et
al
ruff
et
al
nair
et
al
raviprakash
et
al
bonini
et
al
su
et
al
lu
et
al
marqu
et
al
chikhlikar
et
al
barro
de
arruda
et
al
anwar
et
al
su
et
al
recent
clinic
studi
patient
receiv
dendrit
cell
transfect
rna
encod
htertlamp
chimera
develop
higher
frequenc
htertspecif
tcell
respons
subject
receiv
dendrit
cell
transfect
unmodifi
htert
templat
su
et
al
despit
abund
evid
increas
immun
respons
lamp
chimera
antigen
protein
biolog
consequ
enhanc
immun
respons
relat
protect
immun
defin
remain
critic
question
ident
tcell
epitop
lamptarget
antigen
compar
natur
pathogen
lamp
traffick
normal
mechan
antigen
access
mhc
class
ii
compart
antigenpres
cell
epitop
specif
antigen
process
present
vivo
comparison
antigen
deliveri
system
remain
demonstr
present
studi
use
sever
acut
respiratori
syndrom
coronaviru
sar
cov
nucleocapsid
n
model
antigen
address
issu
immun
respons
tcell
epitop
present
function
antigen
formul
n
protein
amino
acid
abundantli
express
highli
immunogen
lau
et
al
huang
et
al
primari
function
structur
protein
viru
assembl
bind
sar
cov
rna
format
ribonucleoprotein
complex
huang
et
al
previou
studi
shown
n
protein
lin
et
al
zhao
et
al
dna
encod
n
kim
et
al
zhu
et
al
yang
et
al
elicit
antibodi
cytotox
tcell
respons
mice
analysi
effect
immunogen
formul
deliveri
immun
respons
vivo
util
three
form
n
deliveri
recombin
ngst
protein
combin
freund
adjuv
classic
exogen
antigen
condit
profound
activ
innat
immun
respons
n
encod
dna
plasmid
unmodifi
endogen
cytoplasmicnuclear
antigen
dna
construct
n
insert
lumin
domain
entir
molecul
unnatur
endogen
antigen
target
lumin
compart
endosomallysosom
vesicl
guarnieri
et
al
valid
n
express
pn
plampn
dna
construct
carri
analyz
cell
transfect
vitro
cdna
encod
n
protein
prepar
rtpcr
nspecif
primer
sar
rna
purifi
singapor
clinic
isol
genbank
access
correspond
n
sequenc
insert
vector
kessler
et
al
form
wildtyp
pn
dna
express
vector
construct
posit
lamp
transmembran
domain
make
phlampn
vector
fig
western
blot
analysi
n
cell
lysat
cultur
supernat
transfect
cell
show
presenc
kda
n
protein
compar
level
cell
lysat
cultur
supernat
pn
phlampntransfect
cell
variou
form
higher
molecular
weight
lampn
chimera
cell
lysat
cultur
supernat
phlampntransfect
cell
fig
nlike
protein
cell
lysat
phlampntransfect
cell
attribut
cleavag
n
proteaseresist
lamp
stage
cellular
traffick
molecul
intact
nearintact
gag
protein
also
observ
cell
transfect
correspond
lampgag
dna
vaccin
construct
sever
form
larger
lampn
molecul
also
present
cell
lysat
cultur
supernat
transfect
cell
intact
lampn
found
kda
band
attribut
variou
degrad
product
howev
cautiou
presum
cell
traffick
pathway
newli
synthes
n
lack
endoplasm
reticulum
transloc
signal
sequenc
cell
cytoplasm
contrast
lampn
chimera
expect
traffic
endosom
lysosom
vesicl
lamp
vesicular
traffick
sequenc
use
confoc
microscopi
valid
traffick
destin
immunoreact
unmodifi
n
antigen
n
lampn
chimera
express
transfect
mous
lb
b
cell
human
melanoma
meljuso
cell
compar
cellular
distribut
endogen
express
mhc
class
ii
protein
fig
coloc
endogen
lamp
mhc
class
ii
protein
vesicular
compart
apc
extens
document
kleijmeer
et
al
geuz
murk
et
al
traffick
lampn
chimera
protein
lamp
mhc
ii
compart
transfect
cell
valid
coloc
lampn
chimera
label
antin
antibodi
endogen
mhc
class
ii
mous
b
fig
greater
definit
local
n
transfect
cell
obtain
analyz
immunolabel
ultrathin
cryosect
mous
lb
b
cell
endocyt
compart
b
cell
morpholog
similar
report
mous
bcell
line
b
welldefin
multivesicular
multilaminar
miic
end
organel
geuz
doubl
immunogold
label
transfect
b
cell
confirm
n
lampn
chimera
present
endogen
lamp
mhc
class
ii
molecul
miic
multilaminar
vesicl
fig
b
contrast
unmodifi
n
predominantli
local
cytoplasm
vacuol
structur
evid
coloc
lamp
mhc
class
ii
fig
remark
lower
power
magnif
show
cytoplasm
vesicl
contain
larg
amount
n
vesicl
may
correspond
strongli
label
vesicular
structur
shown
immunofluoresc
microscopi
presenc
n
structur
suggest
possibl
rout
secret
protein
fig
n
antigen
three
form
repres
differ
antigen
deliveri
adjuv
peptid
process
pathway
administ
accord
follow
protocol
n
exogen
ngst
protein
administ
three
time
day
one
week
later
initi
cfa
ifa
n
unmodifi
endogen
dnaencod
cytoplasm
protein
n
artifici
chimera
encod
lumin
domain
lamp
target
cellular
lysosom
mhc
ii
compart
administ
five
time
day
week
later
without
ad
adjuv
subject
molecular
adjuv
effect
dna
cpg
motif
target
lampn
chimera
mhc
ii
compart
dna
encod
phlamp
use
neg
control
tcell
respons
assay
ifng
elispot
elisa
assay
use
spleen
cell
collect
day
final
dna
immun
assay
cell
stimul
nhi
protein
posit
control
librari
overlap
n
peptid
amino
acid
length
result
confirm
three
experi
multipl
assay
three
independ
set
peptid
differ
sourc
ifng
respons
also
assay
elisa
protocol
similar
result
data
shown
strongest
ifng
respond
cell
mice
immun
phlampn
compar
weaker
respons
pnimmun
mice
minim
respons
cell
ngstimmun
mice
tabl
fig
major
group
ifng
respons
elicit
peptid
amino
acid
sequenc
n
encompass
overlap
peptid
recent
result
also
confirm
new
experiment
protocol
current
conduct
also
show
peptid
encompass
n
elicit
elispot
respons
data
shown
domin
respons
peptid
n
n
overlap
peptid
n
n
signific
epitopespecif
respons
pn
ngstimmun
mice
share
phlampnimmun
mice
weak
ifng
respons
ngst
protein
immun
mice
observ
peptid
elicit
strongest
respons
splenocyt
dnaplasmidimmun
mice
fig
c
compar
weak
ifng
respons
ngstimmun
mice
mark
contrast
strong
respons
shown
except
strong
antibodi
respons
nspecif
antibodi
titer
ngst
immun
day
first
boost
day
second
boost
compar
titer
increas
maximum
day
respons
immun
pn
phlampn
dna
construct
memori
immun
respons
total
igg
antibodi
titer
ctl
activ
elispot
ifng
respons
examin
use
separ
experiment
protocol
group
mice
treat
three
n
antigen
prepar
receiv
three
inocul
week
interv
week
memori
immun
respons
activ
singl
inject
week
pn
construct
surrog
viru
infect
antibodi
tcell
elispot
ctl
respons
measur
immedi
pn
inject
week
three
time
week
interv
thereaft
fig
tcell
assay
conduct
select
peptid
elicit
immunodomin
respons
pilot
experi
ctl
n
residu
tcell
ifng
respons
mice
sacrif
day
pn
memori
activ
low
signific
mice
initi
immun
phlampn
fig
follow
recal
pn
inject
increas
ifng
respons
observ
day
reach
appar
maximum
day
strongest
memori
tcell
respons
assay
mice
initi
immun
phlampn
strong
ifng
respons
peptid
ngst
plu
freund
adjuv
elicit
strong
respons
minim
ifng
respons
seen
primari
respons
respons
mice
initi
immun
pn
uniformli
lower
seen
lamp
chimera
respons
ngst
howev
ifng
respons
greater
pn
ngst
memori
ctl
respons
strongest
phlampnimmun
mice
much
weaker
respons
pn
dna
immun
littl
immun
ngst
adjuv
fig
memori
antibodi
respons
follow
pattern
primari
respons
much
stronger
igg
titer
day
follow
activ
ngstimmun
mice
compar
respons
phlampnimmun
mice
rel
littl
respons
mice
initi
immun
pn
peptid
epitop
activ
cell
reli
receptor
tcr
recognit
complex
antigen
peptid
sequenc
bound
nine
amino
acid
bind
cleft
mhc
class
ii
molecul
benacerraf
postul
kinet
stabil
mhcpeptid
complex
key
paramet
dictat
immunodomin
lazarski
et
al
analysi
tcell
epitop
specif
n
predict
class
l
class
ii
ie
ia
bind
motif
sar
n
overlap
peptid
examin
murin
immunoinformat
system
base
quantit
matric
pred
balbc
zhang
et
al
nineaminoacid
sequenc
n
analyz
bind
core
sequenc
allel
nine
ifng
elispotposit
peptid
score
high
probabl
bind
class
andor
class
ii
allel
tabl
ongo
experi
new
set
peptid
encompass
n
elicit
respons
data
shown
present
studi
demonstr
domin
tcell
immun
respons
mice
immun
sar
cov
n
protein
plu
adjuv
dna
encod
two
differ
cellular
traffick
form
n
direct
peptid
epitop
three
immunogen
find
point
exist
versatil
antigenprocess
mechan
defin
initi
site
deliveri
protein
whether
exogen
endogen
state
innat
respons
immunogen
data
consist
multipl
vivo
rout
antigen
access
proteolyt
process
compart
produc
compar
mhc
ii
peptid
epitop
versatil
would
elispot
respons
group
domin
peptid
shown
peptid
number
amino
acid
region
n
sequenc
number
ifngposit
cell
mice
immun
three
immunogen
cluster
n
peptid
aa
overlap
contain
strongest
domin
epitop
preclud
quantit
variat
epitop
present
result
differ
level
antigen
degre
process
access
cellular
compart
antigen
present
exampl
studi
greater
respons
lampn
chimera
could
relat
quantit
greater
deliveri
n
mhc
class
ii
compart
apc
also
major
differ
repertoir
function
cell
respond
given
epitop
differ
ifng
respons
mice
immun
dna
ngst
plu
cfa
other
report
similar
find
ctldefin
epitop
peptid
gener
exogen
protein
plasmid
dnaencod
antigen
schirmbeck
et
al
effici
mhc
class
crosspresent
peptid
deriv
exogen
antigen
compar
present
classic
mhc
class
ii
pathway
storni
bachmann
addit
ria
et
al
compar
respons
hen
eggwhit
lysozym
hel
reduc
carboxymethyl
form
rcmhel
found
rcmhel
induc
vivo
tcell
respons
focus
immunodomin
determin
character
respons
nativ
hel
rcmhel
respons
skew
toward
pathway
differ
effici
process
observ
hel
rcmhel
conclud
makeup
tcell
epitop
antigen
primarili
determin
amino
acid
composit
protein
context
peptid
bind
site
mhc
molecul
mechan
deliveri
protein
find
support
use
novel
immunogen
antigen
chimera
dna
vaccin
encod
antigen
modifi
cell
traffick
signal
vaccin
candid
despit
differ
normal
pathogen
protein
term
antigen
structur
deliveri
process
mechan
differ
result
obtain
three
antigen
prepar
larg
relat
charact
magnitud
immun
respons
mice
immun
exogen
n
protein
plu
freund
adjuv
respond
greatli
enhanc
antibodi
respons
high
ratio
tcell
ifng
respons
antigen
peptid
contrast
peptid
elicit
balanc
ifng
respons
lower
antibodi
respons
mice
immun
dna
vaccin
freund
adjuv
associ
preferenti
induct
tcell
respons
shibaki
katz
yip
et
al
billiau
matthi
differ
tcell
cytokin
respons
epitop
varga
et
al
attribut
variabl
express
pattern
singl
cell
popul
reflect
transient
rather
herit
differ
express
profil
kelso
grove
kelso
et
al
anoth
differ
vaccin
compar
poor
memori
respons
ngst
protein
pn
dna
construct
compar
phlampn
chimera
construct
limit
efficaci
convent
pn
dna
construct
consist
mani
previou
studi
laboratori
martin
et
al
maecker
et
al
oehen
et
al
rush
et
al
marqu
et
al
barro
de
arruda
et
al
although
like
multipl
factor
involv
memori
tcell
differenti
masopust
et
al
attribut
enhanc
tcell
memori
respons
plampn
least
part
increas
effici
traffick
lampn
chimera
mhc
ii
compart
apc
local
domin
tcell
respons
cluster
overlap
peptid
epitop
within
n
similar
find
ongo
studi
gag
yellow
fever
viru
envelop
protein
major
tcell
respons
fig
primari
tcell
ifng
elispot
respons
phlampn
b
pn
c
ngstimmun
mice
describ
materi
method
mice
immun
five
time
dna
immunogen
three
time
ngst
plu
adjuv
mice
sacrif
elispot
assay
antigenspecif
splenocyt
ifng
secret
day
final
immun
splenocyt
stimul
recombin
nhi
protein
n
peptid
panel
overlap
peptid
span
entir
molecul
mice
immun
hlamp
plasmid
neg
control
signific
tcell
peptidespecif
ifng
respons
elicit
immunogen
stimul
peptid
strongest
respons
phlampn
weakest
ngst
also
involv
cluster
epitop
unpublish
observ
region
overlap
tcell
epitop
also
report
studi
protein
shankar
et
al
surman
et
al
brown
et
al
berzofski
et
al
outer
membran
protein
chlamydia
trachomati
kim
demar
predict
hla
tcell
epitop
srinivasan
et
al
zhang
et
al
cluster
tcell
epitop
appear
common
perhap
ubiquit
occurr
may
facilit
develop
epitopebas
vaccin
singl
hot
spot
elicit
requir
tcell
function
basi
hot
spot
unknown
like
relat
measur
bind
affin
peptid
sequenc
mhc
molecul
well
function
paramet
affect
mhc
peptid
bind
tcell
receptor
tcell
activ
chen
et
al
analysi
nonamer
mhc
bind
motif
sar
n
newli
develop
pred
balbc
comput
system
predict
probabl
bind
nineaminoacid
sequenc
antigen
class
l
class
ii
ie
ia
bind
motif
zhang
et
al
show
sar
n
peptid
elicit
elispotposit
ifng
tcell
respons
contain
highprob
bind
motif
mhc
class
andor
ii
allel
may
also
protein
structur
effect
select
epitop
hot
spot
threedimension
structur
n
aminotermin
domain
n
truncat
model
lack
n
n
determin
nmr
spectroscopi
huang
et
al
two
elispotposit
sequenc
n
n
present
expos
surfac
structur
n
tcell
hot
spot
sequenc
also
contain
n
sequenc
report
compris
b
cell
epitop
huang
et
al
associ
tand
bcell
epitop
also
found
hiv
envelop
seen
present
expos
loop
strand
map
onto
crystal
structur
protein
brown
et
al
del
porto
et
al
shirai
et
al
mous
b
lymphoma
monkey
kidney
cell
line
obtain
atcc
rockvil
md
human
melanoma
cell
line
meljuso
obtain
german
collect
microorgan
cell
cultur
braunschweig
germani
insect
cell
line
obtain
invitrogen
cell
line
maintain
accord
supplier
protocol
sar
cov
nucleocapsid
n
cdna
prepar
singapor
clinic
isol
purifi
total
rna
bp
n
gene
sequenc
obtain
pcr
primer
nhei
kpni
site
pcr
product
clone
express
vector
contain
aavitr
sequenc
flank
express
element
cmv
promot
kessler
et
al
make
wildtyp
plasmid
pn
nsequenc
without
stop
codon
amplifi
xholi
ecori
site
introduc
use
primer
phlampn
chimera
vector
construct
substitut
hivgag
sequenc
phlampgag
vector
due
presenc
intern
nhei
xhoi
site
n
sequenc
pn
phlampn
plasmid
construct
sequenti
clone
two
fragment
n
gene
sarscov
n
amplifi
rtpcr
sequenc
use
forward
primer
ecori
site
revers
primer
noti
site
cdna
sequenc
clone
ecori
noti
site
invitrogen
kind
gift
dr
roland
institut
molecular
cell
biolog
singapor
pfastbac
hta
invitrogen
carlsbad
ca
vector
clone
verifi
sequenc
nspecif
bind
motif
analyz
pred
balbc
system
ifng
elispot
peptid
contain
multipl
nine
amino
acid
bind
motif
within
top
bind
score
five
allel
ifng
elispot
peptid
except
n
score
predict
contain
class
bind
motif
similarli
class
ii
bind
motif
predict
except
n
n
express
n
protein
vaccin
plasmid
pn
plampn
cell
line
analyz
western
blot
analysi
cell
transfect
sar
plasmid
use
polyfect
transfect
reagent
qiagen
gmbh
cell
cultur
polyacrylamid
gel
electrophoresi
carri
describ
n
protein
detect
incub
polyclon
serum
mice
immun
ngst
protein
follow
horseradishperoxidaseconjug
goat
antimous
igg
monoclon
antibodi
pierc
biotechnolog
bind
secondari
antibodi
visual
supersign
west
pico
chemiluminesc
kit
dab
pierc
biotechnolog
recombin
n
protein
gener
use
two
dna
plasmid
express
system
ngst
e
coli
use
antigen
mous
immun
nhi
baculoviru
system
antigen
elisa
elispot
assay
recombin
n
protein
express
gst
fusion
e
coli
cell
invitrogen
iptg
induct
protein
purifi
affin
chromatographi
glutathion
sepharos
bead
amersham
pharmacia
biotech
ab
prepar
valid
western
blot
analysi
use
mous
monoclon
antigst
santa
cruz
biotechnolog
rabbit
polyclon
antin
imgenex
antibodi
bac
bac
baculoviru
express
system
version
c
invitrogen
use
n
protein
express
insect
cell
pfastbachtan
construct
clone
ecoriand
notidigest
sar
cov
n
fragment
pfastbachta
vector
n
protein
purifi
lysat
infect
cell
use
ninta
agaros
bead
invitrogen
protein
prepar
verifi
western
blot
analysi
mous
monoclon
pentahisantibodi
qiagen
gmbh
antin
imgenex
antibodi
purif
cultur
product
express
system
yield
fraction
enrich
ngst
nhi
protein
cellular
local
express
viral
protein
transfect
mous
b
lymphoma
cell
studi
confoc
immunoelectron
microscopi
confirm
confoc
microscopi
transfect
human
meljuso
cell
cell
transfect
sar
cov
plasmid
phlampn
pn
use
polyfect
qiagen
gmbh
express
recombin
viral
protein
visual
use
rabbit
polyclon
antin
imgenex
mous
monoclon
antihuman
antibodi
obtain
supernat
hybridoma
cultur
prepar
laboratori
local
transgen
protein
mhcclassiicontain
compart
lysosom
b
cell
determin
use
antimous
mhc
class
ii
antibodi
bd
bioscienc
antimous
antibodi
prepar
laboratori
local
viral
protein
mhc
class
iicontain
compart
meljuso
cell
analyz
antihladr
dp
dq
antibodi
bd
pharmingen
rabbit
antin
antibodi
imgenex
three
immun
protocol
carri
three
group
phlamp
control
pn
phlampn
immunogen
femal
week
old
balbc
mice
per
group
immun
subcutan
base
tail
ag
specifi
endotoxinfre
dna
plasmid
dilut
pb
day
blood
sampl
collect
phlebotomi
tail
vein
day
anim
sacrif
day
day
last
immun
anoth
group
immun
intraperiton
ag
ngst
protein
emulsifi
cfa
follow
two
booster
immun
week
apart
ngst
protein
emulsifi
ifa
blood
sampl
collect
outlin
day
anim
sacrif
day
day
last
immun
protocol
carri
twice
five
mice
per
group
time
addit
protocol
carri
analysi
memori
respons
four
group
mice
phlamp
control
pn
phlampn
ngst
immunogen
immun
outlin
three
inject
week
week
interv
week
memori
immun
respons
activ
singl
inject
pn
construct
phlamp
neg
control
three
mice
group
sacrif
day
final
pn
inject
weekli
interv
week
thereaft
experi
perform
approv
john
hopkin
univers
anim
care
use
committe
protocol
number
antisar
cov
n
igg
antibodi
serum
mous
assay
elisa
seroconvers
dilut
total
igg
titer
serial
dilut
start
determin
standard
quantit
elisa
brief
elisa
plate
maxisorb
nunc
inc
coat
overnight
c
agml
recombin
nhi
protein
pb
follow
block
elisa
buffer
pb
contain
milk
tween
wash
appropri
dilut
mous
serum
ad
incub
h
room
temperatur
total
igg
detect
mous
extravidin
alkalin
phosphatas
stain
kit
sigma
respons
antigenspecif
cell
immun
mice
measur
use
ifng
elispot
set
bd
pharmingen
accord
manufactur
protocol
splenocyt
stimul
agml
recombin
nhi
baculovirusproduc
agml
overlap
sar
cov
synthet
peptid
three
sourc
nih
aid
research
refer
reagent
program
rockvil
md
synpep
corp
dublin
ca
john
hopkin
biochemistri
core
facil
neg
control
stimul
produc
less
five
spot
per
well
experi
averag
number
spot
neg
control
well
experi
repeat
least
twice
differ
group
mice
two
immun
cytotox
tlymphocyt
assay
ctl
assay
perform
use
cytotox
nonradioact
cytotox
assay
kit
promega
corpor
usa
pool
splenocyt
two
mice
ngst
group
three
mice
group
obtain
time
point
day
memori
recal
pn
stimul
vitro
two
peptid
n
n
final
concentr
agml
day
target
cell
puls
overnight
separ
ag
ml
two
peptid
wash
two
time
resuspend
rpmi
supplement
fc
seed
onto
ubottom
plate
cellswel
al
cultur
medium
equal
volum
pool
invitrostimul
splenocyt
recal
mice
effector
cell
differ
effectortarget
ratio
incub
done
quadrupl
neg
control
contain
equal
concentr
unrel
peptid
control
effector
cell
spontan
releas
target
spontan
releas
target
maximum
releas
includ
assay
valu
comput
mean
standard
deviat
four
replic
assay
subtract
averag
valu
obtain
neg
control
use
overlap
peptid
antivir
tcell
respons
describ
maecker
et
al
draenert
et
al
balbc
mous
tcell
bind
motif
overlap
n
peptid
predict
use
pred
balbc
class
l
class
ii
ie
model
zhang
et
al
pred
balbc
system
score
bind
index
immunogen
nineaminoacid
sequenc
molecul
base
quantit
matric
